Moderna cancels plans to build mRNA manufacturing site in Japan

Mod­er­na is aban­don­ing plans to build an mR­NA drug sub­stance pro­duc­tion fa­cil­i­ty in Fu­ji­sawa, Japan, af­ter “care­ful con­sid­er­a­tion giv­en the cur­rent busi­ness en­vi­ron­ment,” in the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.